Treat to Target in Hyperlipidemia: Concept or Reality?
Educational information
This session is recorded at Master Class - PCSK9 Inhibition in Clinical Lipid Management
Disclosures
Dr Peter Lansberg, - CEO and Lipid Specialist at Lansberg Consultants - Amsterdam
Funding
The meeting was sponsored by Sanofi Gulf
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: